Open Payments

HOSPITAL FOR SPECIAL SURGERY

Type
Teaching hospital
Where
New York, NY
Medicare CCN
330270
Received
$3,770,906 in 327 records, 2022 ($1,964,693 general, $1,806,213 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2022General payment145$1,964,693
2022Research payment182$1,806,213

By company

CompanyRecordsAmountYears
EXACTECH, INC.5$591,9342022
Lima USA, Inc.16$539,8612022
Stryker Corporation36$341,9762022
Smith+Nephew, Inc.46$300,1602022
Medical Device Business Services, Inc.19$266,4962022
GE Global Research an unincorporated business of GE Company5$216,1132022
Zimmer Biomet Holdings, Inc.32$214,1112022
Novartis Pharmaceuticals Corporation3$182,8042022
Medtronic, Inc.16$159,1722022
NuVasive, Inc.3$150,0002022
UCB SA7$123,5072022
Synthes GmbH3$65,0002022
ABBVIE INC.14$57,2972022
E.R. Squibb & Sons, L.L.C.4$56,0522022
Orthofix Medical, Inc.4$54,1912022
SI-BONE, INC.6$44,2852022
Regeneron Pharmaceuticals, Inc.1$38,4882022
Mallinckrodt Hospital Products Inc.1$33,7322022
Takeda Pharmaceuticals U.S.A., Inc.32$33,1222022
AstraZeneca Pharmaceuticals LP2$33,0562022
PFIZER INC.4$30,4502022
KCI USA, Inc.3$23,8342022
Alexion Pharmaceuticals, Inc.3$21,2582022
ARGENX US, INC.5$20,7072022
DJO, LLC1$18,8572022
AMAG Pharmaceuticals, Inc.4$18,1672022
Amgen Inc.2$16,8492022
Pacira Pharmaceuticals Incorporated1$15,0002022
Heron Therapeutics, Inc.1$12,0002022
SANOFI US SERVICES INC.3$11,6492022
AstraZeneca UK Limited2$11,3202022
UOC USA INC2$11,0002022
Ortho Development Corporation12$10,7402022
Arthrex, Inc.1$9,5852022
ILLUMINOSS MEDICAL, INC.1$5,8772022
Viseon, Inc.2$5,5422022
Siemens Medical Solutions USA, Inc.1$4,5002022
TREACE MEDICAL CONCEPTS, INC.1$4,4612022
Apellis Pharmaceuticals, Inc.1$3,6752022
CSL Behring2$2,7552022
Janssen Biotech, Inc.1$2,5002022
Boehringer Ingelheim Pharmaceuticals, Inc.1$1,8422022
Boehringer Ingelheim Pharma GmbH & Co.KG1$1,6562022
ZIMVIE INC.1$1,6252022
Globus Medical, Inc.1$1,5002022
Masimo Corporation13$1,0572022
Paragon 28, Inc.1$9272022
Horizon Therapeutics plc1$2022022

By nature of payment

NatureRecordsAmount
Research payment182$1,806,213
Space rental or facility fees (teaching hospital only)56$830,257
Royalty or License16$601,675
Grant42$454,996
Debt forgiveness7$43,788
Compensation for services other than consulting, including serving as faculty or as a speaker at a v8$16,040
Consulting Fee2$11,000
Education1$5,877
Long term medical supply or device loan13$1,057

Records

DateCompanyAmountNatureFormProductStudyYear
2022-12-31Siemens Medical Solutions USA, Inc.$4,500Research paymentIn-kind items and servicesHSSPotterMSKClinicalMR20212022
2022-12-31AstraZeneca UK Limited$3,309Research paymentIn-kind items and servicesSAPHNELO Biological, Inflammation and AutoimmunityThe purpose of this study is to characterise longterm safety and tolerability of intravenous anifrolumab A Multicentre R2022
2022-12-31AstraZeneca Pharmaceuticals LP$2,544Research paymentIn-kind items and servicesFASENRA Biological, RespiratoryA Randomised, Double-blind, Active-controlled 52-week Study with an Open-label Extension to Evaluate the Efficacy and Sa2022
2022-12-31Stryker Corporation$1,351Debt forgivenessCash or cash equivalent2022
2022-12-31ABBVIE INC.$1,092Research paymentIn-kind items and servicesA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-12-29UOC USA INC$3,575Consulting FeeCash or cash equivalentU-Motion II Device, United Hip System2022
2022-12-21Medical Device Business Services, Inc.$154,035Research paymentCash or cash equivalentMOUNTAINEER Device, Spine2022
2022-12-21ABBVIE INC.$34Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-12-20Smith+Nephew, Inc.$10,137Debt forgivenessCash or cash equivalentDYONICS / BONECUTTER Device, Sports Med Resection2022
2022-12-20Smith+Nephew, Inc.$540Research paymentCash or cash equivalentOR3O Dual Mobility Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2022
2022-12-16Stryker Corporation$28,666Research paymentCash or cash equivalentRIO Device, ROBOTICSSURVIVORSHIP AND OUTCOMES OF ROBOTIC ARM ASSISTED MEDIAL UKA2022
2022-12-15Medical Device Business Services, Inc.$10,000GrantCash or cash equivalent2022
2022-12-15Ortho Development Corporation$180Royalty or LicenseCash or cash equivalentPagoda Device, ORTHOPEDIC DEVICE2022
2022-12-15Smith+Nephew, Inc.$67Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-12-14ABBVIE INC.$5,594Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-12-09Stryker Corporation$20,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentMAKO Device, KNEES, HIPS2022
2022-12-09ARGENX US, INC.$500Research paymentCash or cash equivalentA Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chr2022
2022-12-08Heron Therapeutics, Inc.$12,000Research paymentCash or cash equivalentSUSTOL Drug, CINVSafety Study of Repeat Doses of SUSTOL in Adults2022
2022-12-08Zimmer Biomet Holdings, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentPersona Device, Knees2022
2022-12-01Lima USA, Inc.$32,076Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-12-01Zimmer Biomet Holdings, Inc.$7,272Space rental or facility fees (teaching hospital only)Cash or cash equivalentPersona Device, Knees2022
2022-12-01TREACE MEDICAL CONCEPTS, INC.$4,461Space rental or facility fees (teaching hospital only)Cash or cash equivalentLAPIPLASTY SYSTEM Device, FOOT AND ANKLE2022
2022-11-30Orthofix Medical, Inc.$6,585Research paymentCash or cash equivalentM6-C Device, Prosthesis, Intervertebral DiscM6-C Artificial Cervical Disc IDE Post Approval Study2022
2022-11-29Smith+Nephew, Inc.$1,755Research paymentCash or cash equivalentBIRMINGHAM HIP Device, Recon HipsA Post-Approval Study of the Birmingham Hip Resurfacing (BHR) Radiological System Review2022
2022-11-29Smith+Nephew, Inc.$67Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-11-25Stryker Corporation$5,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentACCOLADE Device, HIPS2022
2022-11-24Takeda Pharmaceuticals U.S.A., Inc.$2,603Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2022
2022-11-23Orthofix Medical, Inc.$13,171Research paymentCash or cash equivalentM6-C Device, Prosthesis, Intervertebral DiscM6-C Artificial Cervical Disc IDE Post Approval Study2022
2022-11-21SANOFI US SERVICES INC.$1,674Research paymentCash or cash equivalentAn Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease Activity in Patient2022
2022-11-18Medtronic, Inc.$50,000Research paymentCash or cash equivalentMedical Device Directive/Up-class2022
2022-11-18Smith+Nephew, Inc.$26,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentTAYLOR SPATIAL FRAME Device, Extremities & Limb Restoration2022
2022-11-15Ortho Development Corporation$356Royalty or LicenseCash or cash equivalentPagoda Device, ORTHOPEDIC DEVICE2022
2022-11-10Smith+Nephew, Inc.$7,485Research paymentCash or cash equivalentOR3O Dual Mobility Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2022
2022-11-10SI-BONE, INC.$4,725Research paymentCash or cash equivalentIFUSE IMPLANT Device, SACROILIAC JOINT DYSFUNCTIONSILVIA2022
2022-11-10Zimmer Biomet Holdings, Inc.$1,500GrantCash or cash equivalent2022
2022-11-09ABBVIE INC.$4,472Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-11-07Smith+Nephew, Inc.$15,000GrantCash or cash equivalent2022
2022-11-07Boehringer Ingelheim Pharmaceuticals, Inc.$1,842Research paymentCash or cash equivalentOFEV Drug, RESPIRATORYExtension2022
2022-11-03Novartis Pharmaceuticals Corporation$163,544Research paymentCash or cash equivalentA TWO-YEAR, PHASE III RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY, EFFICAC2022
2022-11-03Zimmer Biomet Holdings, Inc.$10,000GrantCash or cash equivalent2022
2022-11-03Stryker Corporation$291Research paymentCash or cash equivalentTRITANIUM Device, HIPSTRIDENT II TRITANIUM OUTCOMES STUDY2022
2022-11-02AMAG Pharmaceuticals, Inc.$4,215Research paymentCash or cash equivalentFERAHEME Drug, For the treatment of iron deficiency anemia associated with chronic kidney diseaseEfficacy and Safety of Low-Dose Ferumoxytol for Vascular Suppression in Magnetic Resonance Neurography (MRN)2022
2022-11-02SANOFI US SERVICES INC.$3,422Research paymentCash or cash equivalentAn Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease Activity in Patient2022
2022-11-01Lima USA, Inc.$32,076Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-10-31Medical Device Business Services, Inc.$1,335Research paymentCash or cash equivalentKincise Device, Ortho-HipProspective Randomized Multi Center Post Market study of Anterior Advantage Surgical Approach in Total Hip Arthroplasty 2022
2022-10-27Medtronic, Inc.$11,954Research paymentCash or cash equivalentMAZOR X SYSTEM Device, Image Guided Surgery ProductsInvestigator Sponsored Research2022
2022-10-27Stryker Corporation$2,000Research paymentCash or cash equivalentACCOLADE Device, HIPSMETAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECURFIT ADVANC2022
2022-10-27Stryker Corporation$2,000Research paymentCash or cash equivalentTRIATHLON Device, KNEESMAVRIC MAGNETIC RESONANCE IMAGING USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIATHLON CEMENTLES2022
2022-10-27Stryker Corporation$141Research paymentCash or cash equivalentINFINITY Device, TRAUMA & EXTREMITIESINFINITY WITH ADAPTIS TECHNOLOGY TOTAL ANKLE REPLACEMENT FOLLOW-UP (ITAR2)2022
2022-10-25Medtronic, Inc.$7,500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-10-20Novartis Pharmaceuticals Corporation$14,910Research paymentCash or cash equivalentA RANDOMIZED, PARALLEL GROUP, DOUBLE BLIND, PLACEBO CONTROLLED MULTICENTER PHASE III TRIAL TO INVESTIGATE THE EFFICACY A2022
2022-10-20E.R. Squibb & Sons, L.L.C.$13,902Research paymentCash or cash equivalentORENCIA Biological, ImmunologyAnalysis of T and B Cell Repertoire Changes and CTLA4 Genetics and Gene Expression to Understand the Mechanisms of Treat2022
2022-10-20Stryker Corporation$1,360GrantCash or cash equivalent2022
2022-10-19ABBVIE INC.$34Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-10-17Pacira Pharmaceuticals Incorporated$15,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentIovera Device, Pain Management2022
2022-10-14Medical Device Business Services, Inc.$5,687Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-10-14Ortho Development Corporation$1,663Royalty or LicenseCash or cash equivalentPagoda Device, ORTHOPEDIC DEVICE2022
2022-10-13Zimmer Biomet Holdings, Inc.$20,000GrantCash or cash equivalent2022
2022-10-13ABBVIE INC.$7,690Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-10-12Smith+Nephew, Inc.$13,128Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-10-12Smith+Nephew, Inc.$335Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-10-12Smith+Nephew, Inc.$133Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-10-10ILLUMINOSS MEDICAL, INC.$5,877EducationCash or cash equivalentPhotodynamic Bone Stabilization Procedure Pack Device, Orthopedic2022
2022-10-05Lima USA, Inc.$41,387Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-10-05AMAG Pharmaceuticals, Inc.$2,810Research paymentCash or cash equivalentFERAHEME Drug, For the treatment of iron deficiency anemia associated with chronic kidney diseaseEfficacy and Safety of Low-Dose Ferumoxytol for Vascular Suppression in Magnetic Resonance Neurography (MRN)2022
2022-10-03Takeda Pharmaceuticals U.S.A., Inc.$2,301Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-10-03Takeda Pharmaceuticals U.S.A., Inc.$1,450Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-10-03Takeda Pharmaceuticals U.S.A., Inc.$1,450Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-10-03Takeda Pharmaceuticals U.S.A., Inc.$784Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-10-03Takeda Pharmaceuticals U.S.A., Inc.$50Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-10-01Lima USA, Inc.$32,076Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-09-30EXACTECH, INC.$117,309Royalty or LicenseCash or cash equivalentTRULIANT Device, ORTHOPAEDIC2022
2022-09-30CSL Behring$2,025Research paymentCash or cash equivalentHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2022
2022-09-30CSL Behring$730Research paymentCash or cash equivalentHizentra Biological, ImmunologyA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra) in Adu2022
2022-09-28UOC USA INC$7,425Consulting FeeCash or cash equivalentU-Motion II Device, United Hip System2022
2022-09-28Alexion Pharmaceuticals, Inc.$3,274Research paymentCash or cash equivalentULTOMIRIS Biological, Rare DiseaseRandomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Co2022
2022-09-26UCB SA$1,050Research paymentCash or cash equivalentA RANDOMIZED, OPEN LABEL EXTENSION STUDY TO INVESTIGATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF ROZANOLIXIZU2022
2022-09-23Alexion Pharmaceuticals, Inc.$13,900Research paymentCash or cash equivalentULTOMIRIS Biological, Rare DiseaseA Phase 2 3, Double Blind, Randomized, Placebo Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy an2022
2022-09-21Medtronic, Inc.$10,585Research paymentCash or cash equivalentMAZOR X SYSTEM Device, Image Guided Surgery ProductsInvestigator Sponsored Research2022
2022-09-21Synthes GmbH$6,500GrantCash or cash equivalent2022
2022-09-21AMAG Pharmaceuticals, Inc.$2,242Research paymentCash or cash equivalentFERAHEME Drug, For the treatment of iron deficiency anemia associated with chronic kidney diseaseEfficacy and Safety of Low-Dose Ferumoxytol for Vascular Suppression in Magnetic Resonance Neurography (MRN)2022
2022-09-21Takeda Pharmaceuticals U.S.A., Inc.$1,005Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2022
2022-09-21Takeda Pharmaceuticals U.S.A., Inc.$991Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2022
2022-09-21Takeda Pharmaceuticals U.S.A., Inc.$300Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2022
2022-09-21Takeda Pharmaceuticals U.S.A., Inc.$250Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2022
2022-09-21Takeda Pharmaceuticals U.S.A., Inc.$50Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYTHIS IS A PHASE III, PROSPECTIVE, MULTICENTER STUDY WITH TWO STUDY PARTS (EPOCHS) TO EVALUATE THE EFFICACY, SAFETY, AND 2022
2022-09-19SANOFI US SERVICES INC.$6,553Research paymentCash or cash equivalentAn Open Label, Two-Arm Study to Evaluate the Effect of Rilzabrutinib (PRN1008) on Safety and Disease Activity in Patient2022
2022-09-15Ortho Development Corporation$281Royalty or LicenseCash or cash equivalentPagoda Device, ORTHOPEDIC DEVICE2022
2022-09-13Synthes GmbH$32,500GrantCash or cash equivalent2022
2022-09-12SI-BONE, INC.$100Research paymentCash or cash equivalentIFUSE IMPLANT Device, SACROILIAC JOINT DYSFUNCTIONSILVIA2022
2022-09-09Regeneron Pharmaceuticals, Inc.$38,488Research paymentCash or cash equivalentTCR SEQUENCING AND TRANSCRIPTIONAL PROFILING IN HLA B27 ASSOCIATED DISEASE2022
2022-09-09Smith+Nephew, Inc.$5,474Space rental or facility fees (teaching hospital only)Cash or cash equivalentQ-FIX Device, Sports Med Hip2022
2022-09-09Smith+Nephew, Inc.$1,731Compensation for services other than consulting, including serving as faculty or as a speaker at a vIn-kind items and servicesQ-FIX Device, Sports Med Hip2022
2022-09-08Smith+Nephew, Inc.$1,500Research paymentIn-kind items and services2022
2022-09-07ABBVIE INC.$4,342Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-09-06Masimo Corporation$213Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$213Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$213Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$73Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$73Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$73Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$30Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$30Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$30Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$27Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$27Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$27Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-06Masimo Corporation$27Long term medical supply or device loanIn-kind items and servicesrainbow SET Device, Devices2022
2022-09-04Smith+Nephew, Inc.$3,756Debt forgivenessCash or cash equivalentOR3O Dual Mobility Device, Recon Hips2022
2022-09-01Lima USA, Inc.$32,076Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-09-01Stryker Corporation$16,343Research paymentCash or cash equivalentTRIDENT Device, HIPSMETAL ION LEVELS IN STRYKER TRIDENT II TRITANIUM SYSTEM WITH MDM LINER, CERAMIC HEAD, AND ACCOLADE II OR SECURFIT ADVANC2022
2022-09-01ARGENX US, INC.$337Research paymentCash or cash equivalentA Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chr2022
2022-08-31Medtronic, Inc.$47,377Research paymentCash or cash equivalentMAZOR X SYSTEM Device, Image Guided Surgery ProductsInvestigator Sponsored Research2022
2022-08-29Medical Device Business Services, Inc.$4,381Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-08-25Stryker Corporation$46,342Research paymentCash or cash equivalentMAKO Device, KNEES, HIPSMULTICENTER STUDY FOR ROBOTIC-ARM ASSISTED THA 4.0 SYSTEM WITH INTEGRATION OF PELVIC TILT AND ROM ASSESSMENTS: IMPLANT P2022
2022-08-25Stryker Corporation$30,895Research paymentCash or cash equivalentMAKO Device, KNEES, HIPSMULTICENTER STUDY FOR ROBOTIC-ARM ASSISTED THA 4.0 SYSTEM WITH INTEGRATION OF PELVIC TILT AND ROM ASSESSMENTS: IMPLANT P2022
2022-08-25Stryker Corporation$3,828Research paymentCash or cash equivalentSECUR-FIT Device, HIPSSECURFIT ADVANCED OUTCOMES STUDY2022
2022-08-25Stryker Corporation$200Research paymentCash or cash equivalentSECUR-FIT Device, HIPSSECURFIT ADVANCED OUTCOMES STUDY2022
2022-08-25Smith+Nephew, Inc.$85Research paymentCash or cash equivalentJOURNEY II Device, Recon KneesA Retro-Prospective, Non-randomized, Consecutive Series, SIngle Cohort, Multicenter Adaptive Design Study to Evaluate th2022
2022-08-18UCB SA$45,813Research paymentCash or cash equivalentAN OPEN-LABEL EXTENSION STUDY TO EVALUATE ROZANOLIXIZUMAB IN STUDY PARTICIPANTS WITH GENERALIZED MYASTHENIA GRAVIS2022
2022-08-18Stryker Corporation$19,065Research paymentCash or cash equivalentTRITANIUM Device, HIPSMAVRIC MAGNETIC RESONANCE IMAGING USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIATHLON CEMENTLES2022
2022-08-18Stryker Corporation$12,710Research paymentCash or cash equivalentTRIATHLON Device, KNEESMAVRIC MAGNETIC RESONANCE IMAGING USED TO STUDY DETAILED BONE APPOSITION AND FIXATION OF THE STRYKER TRIATHLON CEMENTLES2022
2022-08-18Zimmer Biomet Holdings, Inc.$10,422Space rental or facility fees (teaching hospital only)Cash or cash equivalentPersona Device, Knees2022
2022-08-17ABBVIE INC.$68Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-08-15Zimmer Biomet Holdings, Inc.$3,833GrantCash or cash equivalent2022
2022-08-15Zimmer Biomet Holdings, Inc.$3,800GrantCash or cash equivalent2022
2022-08-15Zimmer Biomet Holdings, Inc.$3,707GrantCash or cash equivalent2022
2022-08-15Zimmer Biomet Holdings, Inc.$3,450GrantCash or cash equivalent2022
2022-08-15Zimmer Biomet Holdings, Inc.$2,470GrantCash or cash equivalent2022
2022-08-15Zimmer Biomet Holdings, Inc.$1,732GrantCash or cash equivalent2022
2022-08-15Zimmer Biomet Holdings, Inc.$1,332GrantCash or cash equivalent2022
2022-08-15Zimmer Biomet Holdings, Inc.$272GrantCash or cash equivalent2022
2022-08-12ARGENX US, INC.$10,000Research paymentCash or cash equivalentA Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chr2022
2022-08-12ARGENX US, INC.$8,869Research paymentCash or cash equivalentA Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chr2022
2022-08-12SI-BONE, INC.$4,010Research paymentCash or cash equivalentIFUSE IMPLANT Device, SACROILIAC JOINT DYSFUNCTIONSILVIA2022
2022-08-12ARGENX US, INC.$1,000Research paymentCash or cash equivalentA Phase 2 Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Chr2022
2022-08-11Stryker Corporation$19,110Research paymentCash or cash equivalentMAKO Device, KNEES, HIPSSURVIVORSHIP AND OUTCOMES OF ROBOTIC ARM ASSISTED MEDIAL UKA2022
2022-08-11Stryker Corporation$19,110Research paymentCash or cash equivalentMAKO Device, KNEES, HIPSSURVIVORSHIP AND OUTCOMES OF ROBOTIC ARM ASSISTED MEDIAL UKA2022
2022-08-10ABBVIE INC.$4,373Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-08-08E.R. Squibb & Sons, L.L.C.$40,550Research paymentCash or cash equivalentORENCIA Biological, ImmunologyA Randomized Double-Blind, Placebo Controlled Trial of Abatacept (CTLA4-Ig) in Giant Cell Arteritis (ABAGART)2022
2022-08-05Smith+Nephew, Inc.$67,844Research paymentCash or cash equivalentOR3O Dual Mobility Device, Recon HipsProspective Multi-Center study to evaluate the safety and effectiveness of the OR30 Dual Mobility system in primary and 2022
2022-08-04Horizon Therapeutics plc$202Research paymentCash or cash equivalentUPLIZNA Drug, UPLIZNAA RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED PHASE 3 STUDY WITH OPEN-LABEL PERIOD TO EVALUATE THE EFFICAC2022
2022-08-02Medical Device Business Services, Inc.$1,014Research paymentCash or cash equivalentKincise Device, Ortho-HipProspective Randomized Multi Center Post Market study of Anterior Advantage Surgical Approach in Total Hip Arthroplasty 2022
2022-08-01Lima USA, Inc.$32,076Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-08-01Zimmer Biomet Holdings, Inc.$12,434GrantCash or cash equivalent2022
2022-08-01Zimmer Biomet Holdings, Inc.$10,805GrantCash or cash equivalent2022
2022-08-01Zimmer Biomet Holdings, Inc.$7,373GrantCash or cash equivalent2022
2022-08-01Zimmer Biomet Holdings, Inc.$6,161GrantCash or cash equivalent2022
2022-08-01Zimmer Biomet Holdings, Inc.$3,550GrantCash or cash equivalent2022
2022-08-01Zimmer Biomet Holdings, Inc.$3,483GrantCash or cash equivalent2022
2022-08-01KCI USA, Inc.$1,843GrantCash or cash equivalent2022
2022-08-01KCI USA, Inc.$616GrantCash or cash equivalent2022
2022-07-29Smith+Nephew, Inc.$135Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-07-26NuVasive, Inc.$99,910GrantCash or cash equivalent2022
2022-07-26NuVasive, Inc.$35,089GrantCash or cash equivalent2022
2022-07-26NuVasive, Inc.$15,000GrantCash or cash equivalent2022
2022-07-21Orthofix Medical, Inc.$27,848Research paymentCash or cash equivalentM6-C Device, Prosthesis, Intervertebral DiscM6-C Artificial Cervical Disc IDE Post Approval Study2022
2022-07-21Orthofix Medical, Inc.$6,585Research paymentCash or cash equivalentM6-C Device, Prosthesis, Intervertebral DiscM6-C Artificial Cervical Disc IDE Post Approval Study2022
2022-07-21Stryker Corporation$6,000Research paymentCash or cash equivalentINFINITY Device, TRAUMA & EXTREMITIESINFINITY WITH ADAPTIS TECHNOLOGY TOTAL ANKLE REPLACEMENT FOLLOW-UP (ITAR2)2022
2022-07-15Medical Device Business Services, Inc.$11,080Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-07-15Medical Device Business Services, Inc.$5,687Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-07-15Medical Device Business Services, Inc.$4,715Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-07-15Ortho Development Corporation$636Royalty or LicenseCash or cash equivalentPagoda Device, ORTHOPEDIC DEVICE2022
2022-07-14Smith+Nephew, Inc.$3,350Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-07-14Janssen Biotech, Inc.$2,500Space rental or facility fees (teaching hospital only)Cash or cash equivalentTREMFYA Drug, Immunology2022
2022-07-13Smith+Nephew, Inc.$4,686Space rental or facility fees (teaching hospital only)Cash or cash equivalentIntegra Device, Extremity, Upper2022
2022-07-13ABBVIE INC.$402Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-07-11Smith+Nephew, Inc.$5,213Space rental or facility fees (teaching hospital only)Cash or cash equivalentRF20000 Device, Sports Med Resection2022
2022-07-11Smith+Nephew, Inc.$5,212Space rental or facility fees (teaching hospital only)Cash or cash equivalentNA Device, Sports Med Resection2022
2022-07-07AMAG Pharmaceuticals, Inc.$8,900Research paymentCash or cash equivalentFERAHEME Drug, For the treatment of iron deficiency anemia associated with chronic kidney diseaseEfficacy and Safety of Low-Dose Ferumoxytol for Vascular Suppression in Magnetic Resonance Neurography (MRN)2022
2022-07-07ABBVIE INC.$4,571Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-07-07Stryker Corporation$1,500Research paymentCash or cash equivalentTRITANIUM Device, HIPSTRIDENT II TRITANIUM OUTCOMES STUDY2022
2022-07-06Lima USA, Inc.$38,593Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-07-05Medical Device Business Services, Inc.$6,532Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-07-05Apellis Pharmaceuticals, Inc.$3,675Research paymentCash or cash equivalentMERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS2022
2022-07-01Lima USA, Inc.$32,076Space rental or facility fees (teaching hospital only)Cash or cash equivalentPromade Device, Devices2022
2022-06-30EXACTECH, INC.$140,749Royalty or LicenseCash or cash equivalentTRULIANT Device, ORTHOPAEDIC2022
2022-06-27Takeda Pharmaceuticals U.S.A., Inc.$100Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-06-24Takeda Pharmaceuticals U.S.A., Inc.$2,045Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-06-24Takeda Pharmaceuticals U.S.A., Inc.$1,810Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-06-24Takeda Pharmaceuticals U.S.A., Inc.$1,450Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-06-24Takeda Pharmaceuticals U.S.A., Inc.$774Research paymentCash or cash equivalentHYQVIA Biological, IMMUNOLOGYLONG-TERM TOLERABILITY AND SAFETY OF IMMUNE GLOBULIN INFUSION 10% (HUMAN) WITH RECOMBINANT HUMAN HYALURONIDASE (HYQVIA/H2022
2022-06-23Arthrex, Inc.$9,585Research paymentCash or cash equivalentARTHROPLASTY IMPLANTS KNEE & HIP ARTHROPLASTY TOTAL KNEE Device, ARTHROPLASTY - IMPLANTS - KNEE & HIP ARTHROPLASTY - TOTAL KNEESOS Total Knee Arthroplasty Registry2022
2022-06-22EXACTECH, INC.$1,000Space rental or facility fees (teaching hospital only)In-kind items and servicesVANTAGE Device, ORTHOPAEDIC2022
2022-06-21Stryker Corporation$1,200Research paymentCash or cash equivalentCARTIVA SYNTHETIC CARTILAGE IMPLANT Device, TRAUMA & EXTREMITIESCARTIVA GRIP22022
2022-06-20Smith+Nephew, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentREAL INTELLIGENCE Device, Recon Robotics2022
2022-06-16PFIZER INC.$12,900Research paymentCash or cash equivalentXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANTA LONGTERM OPENLABEL FOLLOWUP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS JIA2022
2022-06-16PFIZER INC.$2,000Research paymentCash or cash equivalentXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANTA LONGTERM OPENLABEL FOLLOWUP STUDY OF TOFACITINIB FOR TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS JIA2022
2022-06-16Globus Medical, Inc.$1,500GrantCash or cash equivalentSpine Device, Spine2022
2022-06-15Ortho Development Corporation$830Royalty or LicenseCash or cash equivalentPagoda Device, ORTHOPEDIC DEVICE2022
2022-06-10Medical Device Business Services, Inc.$3,500Space rental or facility fees (teaching hospital only)Cash or cash equivalent2022
2022-06-09ABBVIE INC.$6,412Research paymentCash or cash equivalentA Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PM2022
2022-06-09Smith+Nephew, Inc.$4,506Space rental or facility fees (teaching hospital only)Cash or cash equivalentREAL INTELLIGENCE Device, Recon Robotics2022
2022-06-09Medical Device Business Services, Inc.$4,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2022
2022-06-09Smith+Nephew, Inc.$2,687Compensation for services other than consulting, including serving as faculty or as a speaker at a vIn-kind items and servicesREAL INTELLIGENCE Device, Recon Robotics2022
2022-06-09E.R. Squibb & Sons, L.L.C.$1,591Research paymentCash or cash equivalentORENCIA Biological, ImmunologyTrial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy2022
2022-06-06Medtronic, Inc.$6,351Research paymentCash or cash equivalentMAZOR X SYSTEM Device, Image Guided Surgery ProductsInvestigator Sponsored Research2022
2022-06-06Smith+Nephew, Inc.$665Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-06-06Smith+Nephew, Inc.$67Research paymentCash or cash equivalentSPATIAL FRAME Device, Sports Med KneeA Prospective, Multi-Center Clinical Study to Evaluate the Safety and Performance of the Fast-Fix Flex System for Menisc2022
2022-06-02PFIZER INC.$2,000Research paymentCash or cash equivalentXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANTEFFICACY SAFETY TOLERABILITY AND PHARMACOKINETICS OF TOFACITINIB FOR TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS2022

The latest 200 records of 327.

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Kings CountyNew York city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In New York, NY, county Kings County, NY, state New York; placed by its city name.

MeasurePlace (city or town)
New York, NY
County
Kings County, NY
State
New York
Population B010038,483,8442,631,58019,852,366
Population, 2020 census P18,804,1902,736,07420,201,249
Median age B0100238.236.539.8
Under 18 B0100120.2%22.2%20.5%
65 and over B0100116.6%15.5%17.9%
Households B110013,334,0881,009,9277,722,646
Foreign born B0500236.6%35.3%22.8%
Median household income B19013$80,483$80,263$85,974
Median family income B19113$91,707$88,947$106,873
Per capita income B19301$51,844$47,575$50,712
Poverty rate B1700117.9%19.1%14.0%
Unemployment rate B230258.0%7.9%6.4%
Civilian labor force B230254,392,2971,353,36110,171,766
Mean commute (minutes) B0801340.341.732.6
Bachelor's degree or higher B1500341.6%42.1%40.2%
Housing units B250013,678,4861,100,7728,585,241
Owner-occupied B2500332.8%29.5%54.3%
Renters B2500367.2%70.5%45.7%
Median home value B25077$777,600$905,000$423,800
Median gross rent B25064$1,821$1,833$1,621
White, not Hispanic B0300231.0%36.1%52.8%
Black B0300220.4%26.6%13.4%
Hispanic or Latino B0300228.5%19.0%19.8%
Asian B0300214.6%12.1%9.0%
American Indian and Alaska Native B030020.2%0.1%0.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in New York, NY.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.